Search filters

List of works by Andrea Visentin

A Case of Hemophagocytic Lymphohistiocytosis Triggered by Disseminated Tuberculosis and Hairy Cell Leukaemia after SARS-CoV2 Infection

scientific article published on 07 January 2022

A case of "double hit" mantle cell lymphoma carrying CCND1 and MYC translocations relapsed/refractory to rituximab bendamustine cytarabine (R-BAC) and ibrutinib

scientific article published on 15 July 2020

A scoring system to predict the risk of atrial fibrillation in chronic lymphocytic leukemia

scientific article published on 05 August 2019

Aberrant expression of CD10 and BCL6 in mantle cell lymphoma

scientific article

Abnormal regulation of BCR signalling by c-Cbl in chronic lymphocytic leukaemia

scientific article published on 14 August 2018

Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centers.

scientific article published on 6 October 2017

Anti-sulfatide/galactocerebroside antibodies in immunoglobulin M paraproteinemic neuropathies

scientific article published on 7 August 2017

BCR kinase inhibitors, idelalisib and ibrutinib, are active and effective in Richter syndrome

scientific article published on 05 July 2018

Bendamustine plus rituximab is an effective first-line treatment in hairy cell leukemia variant: a report of three cases.

scientific article published on 28 September 2017

Bendamustine plus rituximab versus R-CHOP as first-line treatment for patients with indolent non-Hodgkin's lymphoma: evidence from a multicenter, retrospective study

scientific article published on 22 April 2016

Bortezomib-based regimens in patients with POEMS syndrome: a case series in newly diagnosed and relapsed patients

scientific article published on 22 January 2019

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study

scientific article published on 01 November 2021

Clinical Characteristics and Outcome of West Nile Virus Infection in Patients with Lymphoid Neoplasms: An Italian Multicentre Study

scientific article published on 08 June 2020

Clinical profile associated with infections in patients with chronic lymphocytic leukemia. Protective role of immunoglobulin replacement therapy.

scientific article published on 20 August 2015

Cortactin expression in non-Hodgkin B-cell lymphomas: a new marker for the differential diagnosis between chronic lymphocytic leukemia and mantle cell lymphoma

scientific article published on 17 November 2018

Cortactin, a Lyn substrate, is a checkpoint molecule at the intersection of BCR and CXCR4 signalling pathway in chronic lymphocytic leukaemia cells.

scientific article published on 17 April 2017

Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival

scientific article published on 26 October 2015

Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact

scientific article published on 02 January 2019

Dabigatran in ibrutinib-treated patients with atrial fibrillation and lymphoproliferative diseases: Experience of 4 cases

scientific article published on 06 September 2018

Direct Pharmacological Targeting of a Mitochondrial Ion Channel Selectively Kills Tumor Cells In Vivo

scientific article

Elevated Lactate Dehydrogenase Has Prognostic Relevance in Treatment-Naïve Patients Affected by Chronic Lymphocytic Leukemia with Trisomy 12

scientific article published on 26 June 2019

Enhanced IL-9 secretion by p66Shc-deficient CLL cells modulates the chemokine landscape of the stromal microenvironment

scientific article published on 12 November 2020

Epidemiology and risk factors of invasive fungal infections in a large cohort of patients with chronic lymphocytic leukemia.

scientific article published on 19 September 2016

Genetic Landscape of Ultra-Stable Chronic Lymphocytic Leukemia Patients.

scientific article published on 22 January 2018

HSP70/HSF1 axis, regulated via a PI3K/AKT pathway, is a druggable target in chronic lymphocytic leukemia

scientific article published on 15 May 2019

Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL

scientific article published on 29 September 2020

Ibrutinib in relapsed hairy cell leukemia variant: a case report and review of the literature

scientific article published on 26 September 2020

In Chronic Lymphocytic Leukemia the JAK2/STAT3 Pathway Is Constitutively Activated and Its Inhibition Leads to CLL Cell Death Unaffected by the Protective Bone Marrow Microenvironment

scientific article published on 04 December 2019

In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics

scientific article published on 2 April 2018

Increase of IgA during ibrutinib therapy reduces infection rate in chronic lymphocytic leukemia (CLL) patients

scientific article published on 09 October 2020

Infections in patients with lymphoproliferative diseases treated with targeted agents: SEIFEM multicentric retrospective study

scientific article published on 15 October 2020

Integrated CLL Scoring System, a New and Simple Index to Predict Time to Treatment and Overall Survival in Patients With Chronic Lymphocytic Leukemia.

scientific article published on 20 June 2015

Leukaemic cells from chronic lymphocytic leukaemia patients undergo apoptosis following microtubule depolymerization and Lyn inhibition by nocodazole

scientific article published on 7 March 2014

Lights and Shade of Next-Generation Pi3k Inhibitors in Chronic Lymphocytic Leukemia

scientific article published on 29 September 2020

Major infections, secondary cancers and autoimmune diseases occur in different clinical subsets of chronic lymphocytic leukaemia patients.

scientific article

Mitochondrial apoptosis is induced by Alkoxy phenyl-1-propanone derivatives through PP2A-mediated dephosphorylation of Bad and Foxo3A in CLL

scientific article published on 23 October 2018

Nerve ultrasound abnormalities mirror the course of varicella zoster virus sensory-motor radiculoplexopathy

scientific article published on 9 December 2016

New responsibilities for aged kinases in B-lymphomas

scientific article published on 01 December 2019

Obinutuzumab, a new anti-CD20 antibody, and chlorambucil are active and effective in anti-MAG antibody polyneuropathy

scientific article published on 27 November 2018

Peripheral nervous system involvement in lymphomas

scientific article published on 08 January 2019

Peripheral neuropathies in chronic lymphocytic leukemia: a single center experience on 816 patients

scientific article published on 7 December 2016

Primary neurolymphomatosis as clinical onset of chronic lymphocytic leukemia.

scientific article

Profiling B cell chronic lymphocytic leukemia by reverse phase protein array: Focus on apoptotic proteins

scientific article published on 16 June 2016

Prognostic and Predictive Effect of IGHV Mutational Status and Load in Chronic Lymphocytic Leukemia: Focus on FCR and BR Treatments

scientific article published on 11 March 2019

Role of miR-15a/miR-16-1 and the TP53 axis in regulating telomerase expression in chronic lymphocytic leukemia

scientific article published on 6 April 2017

Splenic marginal zone lymphoma with a de novo t(8;14)(q24;q32) and a prolymphocytoid evolution responsive to rituximab-bendamustine

scientific article published on 04 May 2018

Targeted activation of the SHP-1/PP2A signaling axis elicits apoptosis of chronic lymphocytic leukemia cells

scientific article published on 15 June 2017

The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia

scientific article published on 18 June 2019

The small GTPase RhoU lays downstream of JAK/STAT signaling and mediates cell migration in multiple myeloma.

scientific article published on 13 February 2018

p66Shc deficiency enhances CXCR4 and CCR7 recycling in CLL B cells by facilitating their dephosphorylation-dependent release from β-arrestin at early endosomes.

scientific article

p66Shc deficiency in the Eμ-TCL1 mouse model of chronic lymphocytic leukemia enhances leukemogenesis by altering the chemokine receptor landscape

scientific article published on 28 February 2019

Paulina is supported by:

About Paulina

Help